Clinical Trial Update: Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated pioglitazone as an adjunct to cognitive-behavioral therapy for relapse prevention in Cocaine Use Disorder; the study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Use Disorder

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Cocaine Use Disorder | Phase 2 | Status: COMPLETED